Clinical Trial Update: Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether cilostazol can prevent stroke recurrence and slow disease progression in cerebral small vessel disease. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Small Vessel Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: First Affiliated Hospital of Chengdu Medical College | Conditions: Cerebral Small Vessel Disease | Phase 4 | Status: NOT_YET_RECRUITING